Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-13
2010-10-26
Padmanabhan, Sreeni (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S647000, C514S626000, C514S289000, C514S817000
Reexamination Certificate
active
07820688
ABSTRACT:
Many chemical and pharmaceutical compositions are known to produce antinociceptive effects that are helpful in relieving pain and inflammation. Both opioids and local anesthetics serve an important function in providing peripheral pain relief. Topical administration of pain-relieving drugs to the periphery offers important advantages over systemic or local, non-topical administration. The present invention provides topical pharmaceutical compositions, formulated with at least one local anesthetic and at least one opioid analgesic in a topical excipient. The present invention also provides methods for relieving pain in a subject through topical administration of the pharmaceutical composition in an amount and a duration sufficient to synergistically potentiate an antinociceptive response. Synergistic potentiation of analgesia through topical administration of a local anesthetic/opioid pharmaceutical composition provides a new and improved approach to peripheral pain management.
REFERENCES:
patent: 4446140 (1984-05-01), Nelson
patent: 4626539 (1986-12-01), Aungst et al.
patent: 5028595 (1991-07-01), Soo
patent: 5321012 (1994-06-01), Mayer et al.
patent: 5523323 (1996-06-01), Maccecchini
patent: 5589480 (1996-12-01), Elkhoury et al.
patent: 5635204 (1997-06-01), Gevirtz et al.
patent: 5654281 (1997-08-01), Mayer et al.
patent: 5686112 (1997-11-01), Liedtke
patent: 5689489 (1997-11-01), Shin
patent: 5814659 (1998-09-01), Elden
patent: 5834480 (1998-11-01), Elkhoury
patent: 5834513 (1998-11-01), Ptchelintsev et al.
patent: 5840731 (1998-11-01), Mayer et al.
patent: 5866143 (1999-02-01), Elkhoury
patent: 5869498 (1999-02-01), Mayer et al.
patent: 5948389 (1999-09-01), Stein
patent: 6191126 (2001-02-01), Gamache
patent: 6383511 (2002-05-01), Cassel
patent: 2000-169378 (2000-06-01), None
patent: WO 94/14427 (1994-07-01), None
patent: WO 97/10815 (1997-03-01), None
patent: WO 98/14427 (1998-04-01), None
patent: WO-98/25614 (1998-06-01), None
patent: WO 98/26770 (1998-06-01), None
patent: WO 98/131358 (1998-07-01), None
patent: WO 00/03716 (2000-01-01), None
Yoji et al. (Interaction of Intrathecally Infused Morphine and Lidocaine in Rats (Part I): Synergistic Antinociceptive Effects, Anesthesiology, Dec. 1998, vol. 89(6), pp. 1455-1463).
Goodman and Gilman (The Pharmacological Basis of Therapeutics, seventh edition, pp. 302-305 and pp. 310-312).
Adams et al. (1993) J. Pharmacol. Exp. Ther. 266(3): 1261-1267.
Atanassoff et al (1997) Anesth. Analg. 84: 1340-1343.
Butterworth and Strichartz (1990) Anesthesiol. 72: 711-734.
Bliss & Collingridge (1993) Nature 361: 31-39.
Catterall (1992) Science 242: 50-61.
Catterall and Mackie (1996) Goodman & Gilman's, The pharmacologic basis of therapeutics, Ninth Edition (Hardman et al eds.) McGraw-Hill pp. 331-347.
Courtney and Strichartz (1987) Handbook of Experimental Pharmacology, vol. 81. (Strichartz ed.) Springer-Verlag pp. 53-94.
Chen et al (1993) Mol. Pharmacol. 44: 8-12.
Hanson (1995) Remington: The Science and Practice of Pharmacy, 17thedition, Mack Publishing Company p. 1146-1153.
Elliot et al. (1994) Pain 56: 69-75.
He and Lee (1998) J. Pharmacol. Exp. Ther. 285: 1181-1186.
Horan et al. (1992) Life Sci. 50: 1535-1541.
Kolesnikov and Pasternak (1999) J. Pharmacol. Exp. Ther. 290(1): 247-252.
Kolesnikov et al. (1996) Eur. J. Pharmacol. 310: 141-143.
Kolenikov et al. (1996) J. Pharmacol. Exp.Ther. 279(2): 502-506.
Kolesnikov et al. (1994) Life Sci. 55: 1393-1398.
Kolesnikov et al. (1993) Proc. Natl. Acad.Sci. USA 90: 5162-5166.
Kolesnikov Y.A. et al. “Peripheral blockade of topical morphine tolerance by ketamine” European Journal of Pharmacology, 1999, 374/2.
Lutz and Pfister (1992) J. Receptor Res. 12: 267-286.
Olson et al. (1989) Peptides 10: 1253-1280.
Pasternak (1993) Clin. Neuropharmacol. 16(1): 1-18.
Portoghese et al. (1992) Eur. J. Pharmacol. 218: 195-196.
Reisine and Pasternak (1996) Goodman & Gilman's, The pharmacological basis of Therapeutics, Ninth Edition (Hardman et al. Eds.) McGraw-Hill pp. 521-555.
Rossi et al (1994) Brain Res. 665: 85-93.
Saito et al. (1998) Anesthesiol. 89: 1455-1463.
Saito et al (1998) Anesthesiol 89: 1464-1470.
Sibinga et al. (1998) Annu. Rev. Immunol. 6: 219-249.
Simon (1991) Medicinal res. Rev. 11: 357-374.
Sofuoglu et al. (1991) J. Pharmacol. Ther. 257(2): 676-680.
Standifer and Pasternak (1997) Cell Signal. 9, (No. ¾): 237-248.
Standifer et al. (1996) Mol. Pharmacol. 50: 293-298.
Trujillo and Akil (1991) Science 251: 85-86.
Yasuda et al (1993) Proc. Natl. Acad.Sci. USA 90: 6736-6740.
Yeung and Rudy (1980) J. Pharmacol. Exp. Ther. 215(3): 633-642.
Kolesnikov Yuri A et al. “Analgesic synergy between topical lidocaine and topical opioids” Journal of Pharmacology and Experimental Therapetics, vo. 295, No. 2, Nov. 2000 pp. 546-551, XP 001080389.
Khoury G F et al. “Intraarticular Morphine, Bupivacaine, and Morphine/Bupivacaine for pain control after knee videoarthroscopy” Anesthesiology, American Society of Anesthesiologists, Philadelphia, PA, US, vol. 77, No. 263, 1992, pp. 263-266, XP000910063.
Kaneko Megumi et al. “Synergistic antinociceptice interaction after epidural coadministration of morphine and lidocaine in rats.” Anesthesiology, vol. 80, No. 1, 1994, pp. 137-150, XP001080405.
Saito Yoji et al. “Interaction of intrathecally infused morphine and lidocaine in rats (Part 1).” Anesthesiology (Hagerstown), vol. 89, No. 6, Dec. 1998 pp. 1455-1463, XP001080402.
Atanassoff Peter G et al. “The effect of intradermal administration of lidocaine and morphine on the response to thermal stimulation.” Anesthesia & Analgesia, vol. 84, No. 6, 1997, pp. 1340-1343, XP001079098.
Roy et al. “Transdermal Delivery of Narcotic Analgesics: Comparative Metabolism and Permeability of Human Cadaver Skin and Hairless Mouse Skin” Journal of Pharmaceutical Sciences, vol. 83 (12) Dec. 1994, pp. 1723-1728.
Roy et al. “Transdermal Delivery of Narcotic Analgesics:Comparative Permeabilities of Narcotic Analgesics Through Human Cadaver Skin”, Pharmaceutical Research, vol. 6(10) 1989, pp. 825-832.
Picard et al, “Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomized controlled trials” Pain , Sep. 72(3) 1997, 309-318.
Moore et al. “The efficacy of locally applied morphine in post-operative pain afterbilateral third molar surgery.” Br J Clin Pharmacol Mar. 1994 37(3):227-30.
Leopold et al. “Percutaneous Penetration of Local Anasthetic Bases: Pharmacodynamic Measurements” The Journal of Investigative Dermatology, vol. 113(3), Sep. 1999, pp. 304-307.
Saito et al. Interaction of Intrathecally Infused Morphine and Lidocaine in Rats (Part 1), Anesthesiology, vol. 89, 1988, pp. 1455-1463.
Raja et al. “Comparison of postoperative analgesic effects of intraarticular bupivacaine and morphine following arthroscopic knee surgery.” Anesthesiology Dec. 1992, 77(6): pp. 1143-1147.
Rosseland et al. “Intra-articular morphine for pain relief after knee arthroscopy” Acta Anaesthesiol Scand Mar. 1999 43(3): 252-7.
Fletcher et al. “Additivity of bupivacaine and morphine for peripheral analgesia in rats.” Fundam Clin Pharmacol. Jul.-Aug. 2000: 14(4), pp. 327-334.
Yarussi et al. “Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: a randomized, double-blind, placebo-controlled study.” Reg. Anesth Pain Med, Mar.-Apr. 1999: 24(2), pp. 142-145.
Rosenstock et al. “Analgesic effect of incisional morphine following inguinal herniotomy under spinal anesthesia” Reg Anesth Mar.-Apr. 1996 21(2), pp. 93-98.
Merriam-Webster's Collegiate Dictionary. 10ed. (1999), “potentiate” p. 912, Merriam-Webster, Incorporated.
Kolesnikov, Yuri A., et al., Analgesic Synergy Between Topical Morphine and Butamben in Mice, Department of Anesthesiology and Laboratory of Molecular Neuropharmacology, Memorial-Sloan Kettering Cancer Center,
Kolesnikov Yuri
Pasternak Gavril
Edwards Angell Palmer & & Dodge LLP
Lauro Peter C.
McMillian Kara R
Memorial Sloan-Kettering Cancer Center
Padmanabhan Sreeni
LandOfFree
Topical anesthetic/opioid formulations and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Topical anesthetic/opioid formulations and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Topical anesthetic/opioid formulations and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4184322